Propranolol vs placebo
- Early pharmacological interventions for universal prevention of post‐traumatic stress disorder (PTSD) 2022 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 86 participantsVery low
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
The review found no eligible studies for this question.
It is very uncertain whether propranolol changes PTSD rate at 3 months compared with placebo (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether duct‐to‐mucosa changes rate of POPF (grade B or C defined according to the 2005 ISGPF… compared with invagination pancreaticojejunostomy (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether duct‐to‐mucosa pancreaticojejunostomy using the modified Blumgart… changes rate of surgical reintervention compared with duct‐to‐mucosa pancreaticojejunostomy using the traditional… (very low certainty).
It is very uncertain whether duct‐to‐mucosa pancreaticojejunostomy using the modified Blumgart… changes rate of postoperative bleeding compared with duct‐to‐mucosa pancreaticojejunostomy using the traditional… (very low certainty).
It is very uncertain whether duct‐to‐mucosa pancreaticojejunostomy using the modified Blumgart… changes overall rate of surgical complications compared with duct‐to‐mucosa pancreaticojejunostomy using the traditional… (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether duct‐to‐mucosa changes postoperative mortality compared with invagination pancreaticojejunostomy (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether duct‐to‐mucosa changes rate of surgical reintervention compared with invagination pancreaticojejunostomy (very low certainty).
It is very uncertain whether duct‐to‐mucosa changes rate of postoperative bleeding compared with invagination pancreaticojejunostomy (very low certainty).
It is very uncertain whether duct‐to‐mucosa changes overall rate of surgical complications compared with invagination pancreaticojejunostomy (very low certainty).
It is very uncertain whether duct‐to‐mucosa changes length of hospital stay (days) compared with invagination pancreaticojejunostomy (very low certainty).
The review found no eligible studies for this question.